je.st
news
1 Tiny Biotech's Blockbuster Opportunity in Heart Disease
2015-03-23 00:02:59| Biotech - Topix.net
The U.S. Food and Drug Administration approved the first cholesterol-busting statin drug more than 20 years ago, and statins' proven ability to cut cholesterol levels has turned them into the most widely used drugs in America. However, for millions of people statin therapy alone fails, and that's why Esperion Therapeutics Lipitor every year, heart disease remains the No.
Tags: heart
opportunity
disease
tiny
Category:Biotechnology and Pharmaceuticals